Launch week offerEnds in00h00m00s

annual Promonthly Pro

Qi Zhao

National Cancer Institute

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (30)

Collaborators (1)

Wenxue Tong

Research Assistant Professor

The Chinese University of Hong Kong (CUHK)

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Qi Zhao

Research Interests

Make your next move.

Explore related searches

Articles (30)

Collaborators (1)

Wenxue Tong

Make your next move.

Qi Zhao

Research Interests

Make your next move.

Explore related searches

Articles (30)

Intelligent Programmable Membrane Nanosponge for Early Virus Blocking

AT1R-Mediated NIR-II/PA Imaging-Guided iCM Exosome Therapy for Myocardial Ischemia

Targeting immune checkpoint B7-H6 in cancer immunotherapy

A plant vesicle-dendritic cell chimera for enhancing cancer immunotherapy

From Axonal Growth to Neurodegeneration: The Dual Role of Neurofilament Dynamics in Health and Disease

AI-assisted development of a TCR-like T cell engager targeting MAGE-A4 against melanoma

An Adiponectin Receptor Agonist Dispersed via Nonencapsulative Exosomes Alleviates Aging-Associated Cardiac Dysfunction

An integrated AI-enabled system using One Class Twin Cross Learning for early gastric cancer detection

Artificial intelligence-assisted design of MAGE-A4 ×CD16 T-cell receptor-like natural killer cell engagers

CDK4/6 Inhibition Induces CD8+T Cell Antitumor Immunity via MIF-Induced Functional Orchestration of Tumor-Associated Macrophages

Electron acceptor motif-manipulated NIR-II AIE photosensitizers synergically induce tumor pyroptosis through multimodal image-guided pure type I photodynamic and photothermal therapy

Engineered apoptotic vesicle mimetics with tunable "eat-me" signaling precisely regulate tumor-associated macrophages for potentiating cancer immunotherapy

Intrapericardial delivery of FAP-CAR-T cells via a ROS-responsive hydrogel to treat cardiac fibrosis

Landscape of T-cell bispecific antibodies in cancer therapy: therapeutic strategies, challenges and future prospection

Luteolin enhances antitumor immunity of B7-H3-targeted bispecific natural killer cell engagers against non-small cell lung cancer

Multimodal framework for early developability assessment to accelerate protein and antibody development

NIR imaging-guided carbon monoxide nanomedicine: Design strategies, stimuli-responsive release, and multimodal synergistic therapies for precision disease treatment

NIR-II Nanomedicine Engineered CAR-NK Cells for Precision Navigation and Potentiating Lung Cancer Immunotherapy by Remodeling Tumor Microenvironment

Tumor-associated macrophages promote chemoresistance to Paclitaxel via activating NOTCH2-JAG1 juxtacrine signaling

Ubiquitin-dependent control of PD-L1 nuclear translocation by DDB1 dictates anti-PD-1 response

Insulin-like growth factor-neutralizing antibodies for cancer therapy

Flavonoids in the Treatment of Non-small Cell Lung Cancer via Immunomodulation: Progress to Date

Development of glypican-3-specific chimeric antigen receptor-modified natural killer cells and optimization as a therapy for hepatocellular carcinoma

Receptor tyrosine kinase-like orphan receptor serves as a potential target in cancer immunotherapy

Clinical Progresses and Challenges of Bispecific Antibodies for the Treatment of Solid Tumors

Palladium-free chemoselective probe for in vivo fluorescence imaging of carbon monoxide

Antibody Recognition of Human Epidermal Growth Factor Receptor-2 (HER2) Juxtamembrane Domain Enhances Anti-Tumor Response of Chimeric Antigen Receptor (CAR)-T Cells

NIR-II excitation self-assembly nanomedicine for targeted NIR-IIa fluorescence imaging-guided cuproptosis-promoted synergistic therapy against triple-negative breast cancer

Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution?

Collaborators (1)

Wenxue Tong

Make your next move.